{{Rsnum
|rsid=11554421
|Gene=WNK1
|Chromosome=12
|position=753986
|Orientation=plus
|ReferenceAllele=G
|MissenseAllele=A
|GMAF=0.07071
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=WNK1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.9 | 19.8 | 79.3
| HCB | 0.0 | 6.7 | 93.3
| JPT | 0.0 | 7.1 | 92.9
| YRI | 0.0 | 0.7 | 99.3
| ASW | 0.0 | 8.8 | 91.2
| CHB | 0.0 | 6.7 | 93.3
| CHD | 0.0 | 7.3 | 92.7
| GIH | 2.0 | 13.0 | 85.0
| LWK | 0.0 | 5.5 | 94.5
| MEX | 0.0 | 8.8 | 91.2
| MKK | 0.0 | 3.9 | 96.1
| TSI | 1.0 | 22.5 | 76.5
| HapMapRevision=28
}}{{Venter SNP
|rsid=11554421
|allele=A
|frequency=
|uid=1103649345460
|type=heterozygous_SNP
|hugo=WNK1
|ensembl gene=ENSG00000060237
|ensembl transcript=ENST00000315939
|sift=
|disease=Defects in WNK1 are a cause of pseudohypoaldosteronism type II (PHAII) (MIM:145260). PHAII is an autosomal dominant disease characterized by severe hypertension, hyperkalemia, and sensitivity to thiazide diuretics which may result from a chloride shunt in the renal distal nephron.
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}